This is a Validated Antibody Database (VAD) review about mouse Pms2, based on 10 published articles (read how Labome selects the articles), using Pms2 antibody in all methods. It is aimed to help Labome visitors find the most suited Pms2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Pms2 synonym: AW555130; Pmsl2

Knockout validation
BD Biosciences
mouse monoclonal (A16-4)
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4a
In order to study the role of Pms2 ATPase domain in male fertility, BD Biosciences Pms2 antibody (BD Biosciences, 556415) was used in western blot knockout validation on mouse samples at 1:500 (fig 4a). DNA Repair (Amst) (2016) ncbi
BD Biosciences
mouse monoclonal (A16-4)
  • western blot; human; 1:2500; loading ...; fig 4a
BD Biosciences Pms2 antibody (BD Biosciences, 556415) was used in western blot on human samples at 1:2500 (fig 4a). elife (2019) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry; human; 1:100; fig s4b
In order to discuss mechanisms involved in the resistance of androgen receptor-targeted therapies, BD Biosciences Pms2 antibody (Abcam, 556415) was used in immunohistochemistry on human samples at 1:100 (fig s4b). Nat Med (2016) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry; human; 1:100; loading ...
BD Biosciences Pms2 antibody (BD Pharmingen, A16-4) was used in immunohistochemistry on human samples at 1:100. JAMA Oncol (2016) ncbi
mouse monoclonal (A16-4)
  • western blot knockout validation; mouse; 1:500; loading ...; fig 4a
In order to study the role of Pms2 ATPase domain in male fertility, BD Biosciences Pms2 antibody (BD Biosciences, 556415) was used in western blot knockout validation on mouse samples at 1:500 (fig 4a). DNA Repair (Amst) (2016) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry; human; 1:100
BD Biosciences Pms2 antibody (BD Biosciences, A16.4) was used in immunohistochemistry on human samples at 1:100. Virchows Arch (2015) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry; human; 1:100
In order to compare the immunohistochemical and genetic profiles found in the three types of endometrial carcinomas, BD Biosciences Pms2 antibody (BD, A16-4) was used in immunohistochemistry on human samples at 1:100. Gynecol Oncol (2015) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry - paraffin section; human
BD Biosciences Pms2 antibody (BD Pharmingen, 556415) was used in immunohistochemistry - paraffin section on human samples . Cancer Genet (2014) ncbi
mouse monoclonal (A16-4)
  • western blot; human
In order to explore DNA repair responses in human pluripotent stem cells, BD Biosciences Pms2 antibody (BD Biosciences, 556415) was used in western blot on human samples . J Biol Chem (2014) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry - paraffin section; human; 1:300
BD Biosciences Pms2 antibody (PharMingen, A16-4) was used in immunohistochemistry - paraffin section on human samples at 1:300. PLoS ONE (2014) ncbi
mouse monoclonal (A16-4)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences Pms2 antibody (BD Biosciences Pharmingen, A16-4) was used in immunohistochemistry - paraffin section on human samples at 1:100. PLoS ONE (2013) ncbi
Articles Reviewed
  1. Abildgaard A, Stein A, Nielsen S, Schultz Knudsen K, Papaleo E, Shrikhande A, et al. Computational and cellular studies reveal structural destabilization and degradation of MLH1 variants in Lynch syndrome. elife. 2019;8: pubmed publisher
  2. Beltran H, Prandi D, Mosquera J, Benelli M, Puca L, Cyrta J, et al. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer. Nat Med. 2016;22:298-305 pubmed publisher
  3. Taieb J, Zaanan A, Le Malicot K, Julie C, Blons H, Mineur L, et al. Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab: A Post Hoc Analysis of the PETACC-8 Trial. JAMA Oncol. 2016;2:643-653 pubmed publisher
  4. Fischer J, Dudley S, Miller A, Liskay R. An intact Pms2 ATPase domain is not essential for male fertility. DNA Repair (Amst). 2016;39:46-51 pubmed publisher
  5. Vanoli A, Argenti F, Vinci A, La Rosa S, Viglio A, Riboni R, et al. Hepatoid carcinoma of the pancreas with lymphoid stroma: first description of the clinical, morphological, immunohistochemical, and molecular characteristics of an unusual pancreatic carcinoma. Virchows Arch. 2015;467:237-45 pubmed publisher
  6. Geels Y, van der Putten L, van Tilborg A, Lurkin I, Zwarthoff E, Pijnenborg J, et al. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium. Gynecol Oncol. 2015;137:245-51 pubmed publisher
  7. Vilar E, Mork M, Cuddy A, Borràs E, Bannon S, Taggart M, et al. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014;207:495-502 pubmed publisher
  8. Lin B, Gupta D, Heinen C. Human pluripotent stem cells have a novel mismatch repair-dependent damage response. J Biol Chem. 2014;289:24314-24 pubmed publisher
  9. Koppensteiner R, Samartzis E, Noske A, von Teichman A, Dedes I, Gwerder M, et al. Effect of MRE11 loss on PARP-inhibitor sensitivity in endometrial cancer in vitro. PLoS ONE. 2014;9:e100041 pubmed publisher
  10. Egoavil C, Alenda C, Castillejo A, Paya A, Peiro G, Sanchez Heras A, et al. Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers. PLoS ONE. 2013;8:e79737 pubmed publisher